PlainRecalls

Aurolife Pharma, LLC

Compiled from official public sources by the publisher.

14 recalls on record · Latest: Jun 28, 2023

Subscribe to new Aurolife Pharma, LLC recalls (RSS)

Agency notice ledger

Federal filing book Aurolife Pharma, LLC LIGHT-BOOK · SINGLE-AGENCY

#1,068 of 14,151 · 14 notices · 0.013% archive

  • BOOK 14 notices
  • RANK #1,068 of 14,151
  • SHARE 0.013% archive
  • AGENCY FDA Drug (14)
  • CAT drugs
  • CATS 3 categories
  • LATEST Jun 28, 2023
  • PHOTO Albertsons Companies,…

Nearest notice-volume peer: Albertsons Companies, Inc. (0 notice gap)

Aurolife Pharma, LLC accounts for about 0.013% of the 104,423-notice archive on 14 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Aurolife Pharma, LLC's standing among 14,151 recalling firms

Aurolife Pharma, LLC ranks 1,068th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Aurolife Pharma, LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

14 1068th of 14151 higher than 13,008 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Aurolife Pharma, LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Aurolife Pharma, LLC holds about 0.013% of archive notices alongside 14 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Jun 28, 2023

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
FDA Drug Moderate Dec 28, 2022

Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
FDA Drug Moderate Apr 6, 2022

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, NDC 13107-014-01.
FDA Drug Moderate Sep 25, 2019

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 62011-0315-1); and b) 30-count cartons (NDC 62011-0315-2) HealthMart PHARMACY, Distributed by McKesson, One Post Street, San Francisco, CA 94104.
FDA Drug Moderate Sep 25, 2019

Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0097-55.
FDA Drug Moderate Sep 25, 2019

Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count cartons, DISCOUNT drug mart FOOD FAIR, Distributed by: Discount Drug Mart, 211 Commerce Drive, Medina, OH 44256, NDC 53943-021-09.
FDA Drug Moderate Sep 25, 2019

fexofenadine hydrochloride tablets USP, 180 mg, 150-count bottle, Member's Mark, Distributed by: Sam's West, Inc., Bentonville, AR 22716, NDC 68196-976-91, UPC 0 78742 23550 9.
FDA Drug Moderate Sep 25, 2019

Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648; Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810.
FDA Drug Moderate Sep 25, 2019

Allergy Relief (fexofenadine hydrochrloride) tablets, 180 mg, 5-count carton, Good Neighbor Pharmacy, Distributed By Amerisource Bergen, 1300 Morris Drive, Chesterbrook, PA 19087, NDC 46122-387-23.
FDA Drug Moderate Sep 25, 2019

Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunswick Pike, Lawrenceville, NJ 08648; NDC 58602-820-09.
FDA Drug Moderate Sep 25, 2019

Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.
FDA Drug Moderate Sep 25, 2019

Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648, NDC 58602-711-21
FDA Drug Moderate Sep 25, 2019

Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-995-62.
FDA Drug Moderate Sep 25, 2019

Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 60000-409-53); b) 30-count cartons (NDC 60000-409-30); c) 45-count bonus cartons (NDC 60000-409-48); d) 45-count cartons (NDC 60000-409-45); CAREone, Distributed by: Foodhold U.S.A., LLC, Landover, MD 20785.

Aurolife Pharma, LLC holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Allergan Sales, LLC 14 Banner Pharmacy Services, LLC 14 Bee Extremely Amazed LLC 14 Dabur India Limited 14

Frequently Asked Questions

How many federal recall notices name Aurolife Pharma, LLC? ▼
PlainRecalls indexes 14 distinct federal recall events naming Aurolife Pharma, LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Aurolife Pharma, LLC sit among other recalling firms? ▼
Aurolife Pharma, LLC ranks #1,068 of 14,151 by distinct recall-event count among 14,151 firms in this archive (92nd percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Aurolife Pharma, LLC's notices? ▼
FDA Drug accounts for 14 of this firm's 14 indexed notices.
What product category dominates Aurolife Pharma, LLC's filing book? ▼
Filings for Aurolife Pharma, LLC span 3 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Aurolife Pharma, LLC: 14 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Aurolife Pharma, LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026